| Nov 20 2024 |
Reflections from the 2024 AJEI Summit: A Focus on Appellate Innovation and Integrity |
Ward and Smith, P.A. |
| Nov 20 2024 |
Spilling Secrets Podcast: Beyond Non-Competes - IP and Trade Secret Assessment Strategies for Employers [Podcast] |
Epstein Becker & Green, P.C. |
| Nov 20 2024 |
FDA Clinical Investigations: New Guidance on Electronic Systems |
Foley & Lardner LLP |
| Nov 20 2024 |
What Every Multinational Company Should Know About … The Most Common Supply Chain Risk-Management Failures (Part I) |
Foley & Lardner LLP |
| Nov 20 2024 |
Five Compliance Best Practices for … Customs Housekeeping |
Foley & Lardner LLP |
| Nov 20 2024 |
That’s [Mis]Classified: What Employers Must Prove to Claim an FLSA Overtime Exemption |
Bradley Arant Boult Cummings LLP |
| Nov 20 2024 |
Private Equity Dives into Niche Sports |
Foley & Lardner LLP |
| Nov 20 2024 |
NLRB General Counsel Targets “Stay-Or-Pay” Provisions and Announces Expanded Remedies For Non-Competes |
Hunton Andrews Kurth |
| Nov 20 2024 |
Theft and Conversion as the Basis for a Violation of Section 337 |
Squire Patton Boggs (US) LLP |
| Nov 19 2024 |
How to Prepare for the Upcoming Filing Deadline Under the Corporate Transparency Act (CTA) |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Nov 19 2024 |
Fostering Innovation in Personalized Medicine: The Patent Eligibility Restoration Act |
Foley & Lardner LLP |
| Nov 19 2024 |
Natural Gas Survives Election, Aims to Thrive Post-Election |
K&L Gates LLP |
| Nov 19 2024 |
Click! FTC Updates Its Negative Option Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 19 2024 |
Alaska Paid Sick Leave Law: Requirements Employers Need to Know |
Jackson Lewis P.C. |
| Nov 19 2024 |
2025 Private Equity Trends Outlook |
Mintz |
| Nov 19 2024 |
Information Sharing in the Trump Administration |
Mintz |
| Nov 19 2024 |
CFPB Urges States to Fill Gaps in Federal Financial Privacy Statutes |
Greenberg Traurig, LLP |
| Nov 19 2024 |
Contractor Successfully Recovers Costs Associated with Government-Mandated COVID-19-Related Quarantine |
Bradley Arant Boult Cummings LLP |
| Nov 19 2024 |
The NLRB Overturns Another Longstanding Rule Involving Employers Expressing Views on Unionization to a “Captive Audience” |
Polsinelli PC |
| Nov 19 2024 |
Sweet Reward: Whistleblower Team Receives Over $8 Million for Reporting Alleged CSID Testing Kickback Scheme |
Tycko & Zavareei LLP |
| Nov 19 2024 |
How to Effectively Utilize the MSHA Closeout Conference |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 19 2024 |
New Outbound Investment Rules Restrict US Investment in China |
Hunton Andrews Kurth |
| Nov 19 2024 |
AI Transcripts and Investment Advisers: Embracing Technology While Meeting SEC Requirements |
Stark & Stark |
| Nov 19 2024 |
DOL Salary Rule Vacated by Texas Court |
Bracewell LLP |
| Nov 19 2024 |
Trump Immigration 2.0: What the Election Means for U.S. Employers |
Squire Patton Boggs (US) LLP |
| Nov 19 2024 |
SECURE 2.0 Changes Effective in 2025: What You Need to Know |
Bradley Arant Boult Cummings LLP |
| Nov 19 2024 |
FinCEN’s Latest FAQs on Beneficial Ownership Reporting: Key Updates and Implications |
Polsinelli PC |
| Nov 19 2024 |
FDA Requests Information on PFAS in Seafood |
Keller and Heckman LLP |
| Nov 19 2024 |
EPA Issues ANPRM under TSCA Section 6 on 6PPD and 6PPD-Quinone |
Bergeson & Campbell, P.C. |
| Nov 19 2024 |
Trending in Telehealth: October 29 – November 11, 2024 |
McDermott Will & Schulte LLP |
| Nov 19 2024 |
Preventing a Crash and Burn: Avoiding Future Business Divorces Through Company Governance That Addresses Minority Partner Concerns |
Bradley Arant Boult Cummings LLP |
| Nov 19 2024 |
What is the TCPA?: Here’s a Quick Background on America’s Anti-Robocall Statute Every Call Center Must Know |
Troutman Amin, LLP |
| Nov 19 2024 |
This Week in 340B: November 12 – 18, 2024 |
McDermott Will & Schulte LLP |
| Nov 19 2024 |
Turning Back Overtime – Texas Judge Strikes Down Salary Threshold Increase |
Ward and Smith, P.A. |
| Nov 18 2024 |
Still in Telemedicine Limbo: DEA Issues Third Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2025 |
Polsinelli PC |
